Clinical Trial Update: Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Nuedexta in treating pseudobulbar affect in patients with Alzheimer's disease; study status terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Pseudobulbar Affect

Drugs mentioned

• NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix | Conditions: Alzheimer's Disease, Pseudobulbar Affect (PBA) | Phase 4 | Status: TERMINATED